rs782365144

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP3BS1_SupportingBS2_Supporting

The NM_002637.4(PHKA1):​c.3443T>G​(p.Ile1148Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,205,241 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. I1148I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000016 ( 0 hom. 7 hem. )

Consequence

PHKA1
NM_002637.4 missense

Scores

7
9
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 9.22

Publications

0 publications found
Variant links:
Genes affected
PHKA1 (HGNC:8925): (phosphorylase kinase regulatory subunit alpha 1) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the skeletal muscle isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9D, also known as X-linked muscle glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. A pseudogene has been found on chromosome 1.[provided by RefSeq, Feb 2010]
PHKA1 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXd
    Inheritance: XL, AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.815
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000134 (15/111819) while in subpopulation AFR AF = 0.000488 (15/30751). AF 95% confidence interval is 0.0003. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 2 XL,AR geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA1NM_002637.4 linkc.3443T>G p.Ile1148Ser missense_variant Exon 31 of 32 ENST00000373542.9 NP_002628.2 P46020-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA1ENST00000373542.9 linkc.3443T>G p.Ile1148Ser missense_variant Exon 31 of 32 1 NM_002637.4 ENSP00000362643.4 P46020-1

Frequencies

GnomAD3 genomes
AF:
0.000134
AC:
15
AN:
111819
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000488
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000491
AC:
9
AN:
183394
AF XY:
0.0000737
show subpopulations
Gnomad AFR exome
AF:
0.000456
Gnomad AMR exome
AF:
0.000109
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000155
AC:
17
AN:
1093422
Hom.:
0
Cov.:
29
AF XY:
0.0000195
AC XY:
7
AN XY:
358902
show subpopulations
African (AFR)
AF:
0.000456
AC:
12
AN:
26305
American (AMR)
AF:
0.0000852
AC:
3
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19346
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30191
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54030
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4123
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
837759
Other (OTH)
AF:
0.0000435
AC:
2
AN:
45933
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000134
AC:
15
AN:
111819
Hom.:
0
Cov.:
22
AF XY:
0.0000589
AC XY:
2
AN XY:
33975
show subpopulations
African (AFR)
AF:
0.000488
AC:
15
AN:
30751
American (AMR)
AF:
0.00
AC:
0
AN:
10533
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3571
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2660
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6056
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53175
Other (OTH)
AF:
0.00
AC:
0
AN:
1509
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000140
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease IXd Uncertain:1
Mar 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1148 of the PHKA1 protein (p.Ile1148Ser). This variant is present in population databases (rs782365144, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of PHKA1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 432361). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
May 26, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3443T>G (p.I1148S) alteration is located in exon 31 (coding exon 31) of the PHKA1 gene. This alteration results from a T to G substitution at nucleotide position 3443, causing the isoleucine (I) at amino acid position 1148 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Aug 22, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A variant of uncertain significance has been identified in the PHKA1 gene. The I1148S variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The I1148S variant is observed in 2/8502 (0.02%) alleles from individuals of African background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I1148S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. However, missense variants in nearby residues have not been reported in Human Gene Mutation Database in association with PHKA1-related disorders (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.70
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.59
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.52
D;T;.;.;T
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.97
D;D;D;D;D
M_CAP
Pathogenic
0.65
D
MetaRNN
Pathogenic
0.82
D;D;D;D;D
MetaSVM
Uncertain
0.63
D
MutationAssessor
Uncertain
2.4
M;.;.;.;.
PhyloP100
9.2
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-4.1
D;D;D;D;D
REVEL
Pathogenic
0.89
Sift
Uncertain
0.0010
D;D;D;D;D
Sift4G
Uncertain
0.0090
D;D;D;D;D
Polyphen
0.99
D;P;P;.;.
Vest4
0.78
MVP
0.96
MPC
0.65
ClinPred
0.41
T
GERP RS
5.2
Varity_R
0.90
gMVP
0.74
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782365144; hg19: chrX-71802303; API